Abstract:The title compound (C26H20CIN3O3) has been synthesized by 1,3-dipolar cycloaddition reaction from isatin, sarcosine and (Z)-4-(4-chlorobenzylidene)-2-phenyloxazol-5(4H)-one through a one-pot procedure, and its structure was confirmed by IR, H-1 NMR, elemental analysis and single-crystal X-ray diffraction analysis. The crystal belongs to the triclinic system, space group P (1) over bar, with a = 9.3903(19), b = 11.398(2), c = 12.603(3) angstrom, a = 83.495(3), beta = 68.988(3), gamma = 67.178(3)degrees, V = 1160.1(4) angstrom(3), Z= 2, M-r = 457.90, D-c = 1.311 g/cm(3), mu = 0.198 mm(-1), F(000) = 476, the final R = 0.0489 and wR = 0.1144 for 3109 observed reflections with I > 2 sigma(I).

(4′S)-4′-Ethyl-3′,10′-dioxo-3′,4′, 7′,8′-tetrahydrospiro-[1,3-dioxolane-2,6′-1′H, 6′H-pyrano[3,4-f]indolizin]-4′-yl N-(1-phenylethyl)carbamate

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

Ethyl (4ar,7s,8s,8as)-1-Oxo-7-Phenyl-3,4,4a,7,8,8a-Hexahydro-1h-Isochromen E-8-Carboxylate

(3As,4s,5r,7as,1 ' R,2a ' S,6 ' S,6a ' S)-5-(2 ',5 '-Dioxo-2a '-Methyl-6 ',6a '-Epoxyperhydroinden-1 '-Yl)-3a,4-epoxy-5-hydroxy-7a-methylperhydro-1h-inden-1-one

Ethyl 3-(Anilinocarbonothioyl)-6-methyl-2,4-diphenyl-1,2,3,4-tetrahydropyrimid Ine-5-Carboxylate

3,7-Dihydroxy-3,7-diphenyl-2h,6h-pyrrolo[3,4-f]isoindole-1,5(3h,7h)-dione Methanol Disolvate

Synthesis and Crystal Structure of 1 '-Methyl-4 '-(4-chlorophenyl)-1h-indole-3-spiro-2 '-Pyrrolidine-3 '-Spiro-4 ''-(2 ''-Phenyloxazole)-2,5 ''(3h,4 '' H)-Dione

4-(O-methoxyphenyl)-1,3,4,4a,5,6,7,8a-octahydro-2h-pyrano[2,3-d]pyrimidine-2-thione

(3R)-Methyl 3-[(2S)-4,6-dimethoxy-2-(4-methoxyphenyl)-3-oxo-2,3-dihydro-1-benzofuran-2-yl]-2-methoxycarbonyl-3-phenylpropionate

(4R,5s)-Methyl 1,3-Dibenzyl-5-[(r)-2-(hydroxydiphenylmethyl)pyrrolidine-1-carbonyl]-2-o Xoimidazolidine-4-Carboxylate

3-(imidazolidin-2-ylidene)-6-methyl-3,4,5,6-tetrahydro-2H-pyran-2,4-dione

(4R,7s)-2-amino-4-(3,4-dimethoxyphenyl)-5-oxo-7-phenyl-5,6,7,8-tetrahydro-4h-chromene-3-carbonitrile Monohydrate

(1S,4r)-N-[(s)-2-hydroxy-1-phenylethyl]-7,7-dimethyl-2-oxobicyclo[2.2.1]heptane-1-carboxamide

Ethyl 3-Amino-4h-thieno[2,3-b]pyridine-2-carboxyl-ate.

9,10,11,12-Tetrachloro-12b-hydroxy-12c-phenyl-1,2,3,3a,5,6,12b,12c-octahydro-8h-cyclopenta[6,7][1,4]oxazepino[5,4-a]isoindol-8-one

4-Isopropyl-n-phenylcyclohexa-1,3-diene-1-carboxamide

(1r,3s)-3-Hydroxymethyl-N-Isopropyl-2,2-Dimethylcyclopropanecarboxamide

Ethyl 1-Acetyl-2 '-Methyl-2-oxo-4 ',5 '-Dihydro-1h-indoline-3-spiro-5 '-Oxazole-4 '-Carboxylate